COMMITMENTS AND CONTINGENCIES (Details Narrative)			3 Months Ended
	May 31, 2023	Dec. 26, 2017 USD ($)	Mar. 31, 2024 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 AUD ($)	Dec. 31, 2023 USD ($)
Property, Plant and Equipment [Line Items]
Research and development expenses			$ 458,155	$ 1,825,792
Research and development expense			397,022			$ 145,349
Future cash			6,356,036			$ 2,287,977
Reduction in force restructuring percentage	35.00%
Vogal Nathan Purchase Agreement [Member]
Property, Plant and Equipment [Line Items]
Royalties percentage		2.00%
Payments for royalties		$ 20,000,000
Vogal Nathan Purchase Agreement [Member] | One Time Milestone [Member]
Property, Plant and Equipment [Line Items]
Long-term purchase commitment, amount		200,000
Vogal Nathan Purchase Agreement [Member] | Additional Milestone [Member]
Property, Plant and Equipment [Line Items]
Long-term purchase commitment, amount		$ 300,000
Other Consulting and Vendor Agreements [Member]
Property, Plant and Equipment [Line Items]
Future cash			1,500,000
Avance Clinical [Member]
Property, Plant and Equipment [Line Items]
Contract cost			2,221,000		$ 3,400,000
Payment of contract cost			1,036,940
Prepaid assets			164,798
Accrued liabilities			52,235
Accounts payable			1,333,641
Research and development expenses			$ 398,744	$ 0